Exosomes: Cell-Free Therapy for Cardiovascular Diseases

J Cardiovasc Transl Res. 2020 Oct;13(5):713-721. doi: 10.1007/s12265-020-09966-7. Epub 2020 Apr 24.

Abstract

Cardiovascular diseases (CVDs) are an important cause of death and disease worldwide. Because injured cardiac tissue cannot be repaired itself, it is urgent to develop other alternate therapies. Stem cells can be differentiated into cardiomyocytes, endothelial cells, and vascular smooth muscle cells for the treatment of CVDs. Therefore, cell therapy has recently been considered a viable treatment option that can significantly improve cardiac function. Nonetheless, implanted stem cells rarely survive in the recipient heart, suggesting that the benefits of stem cell therapy may involve other mechanisms. Exosomes derived from stem cells have a myocardial protection function after myocardial injury, and may be a promising and effective therapy for CVDs. Here, we discuss the application and mechanism of exosomes derived from stem cells in the diagnosis and treatment of CVDs and provide evidence for the application of exosomes in CVDs. Graphical Abstract.

Keywords: Cardiovascular diseases; Exosomes; Stem cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / pathology
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular Diseases / surgery*
  • Exosomes / metabolism
  • Exosomes / transplantation*
  • Humans
  • Myocardium / metabolism
  • Myocardium / pathology*
  • Recovery of Function
  • Regeneration*
  • Stem Cell Transplantation*

Substances

  • Biomarkers